TL;DR
- Foundation models in medical technology 2026: 2026 will be a turning point because foundation models will be scalable to product maturity for the first time.
- CNNs remain indispensable for real-time and certification requirements.
- Hybrid models are the most viable option for medtech manufacturers.
- Modular AI stacks reduce development and validation costs in the long term.
2026 marks a turning point for medtech manufacturers, because for the first time Foundation Models are product and platform-ready enough to strategically expand existing AI stacks - without displacing established, approved CNN solutions.
Medical imaging is therefore facing a structural change: vision foundation models make it possible to expand product portfolios more quickly, reduce development costs and provide scalable AI functionality across device generations. At the same time, classic Convolutional Neural Networks (CNN) models remain an indispensable component of approved, production-ready systems. This article explains why 2026 is a turning point - and how medtech companies can benefit from it strategically.
Why 2026 is a special year for medical technology?
Short answer: Because for the first time, scalable vision foundation models can be combined with existing, regulatory established AI architectures - without jeopardizing product approval.
MedTech companies will be confronted with a twofold dynamic in 2026: On the one hand, the variety of data from medical imaging systems is growing rapidly - from CT, MRI and PET to ultrasound, endoscopy, robotics and digital pathology. On the other hand, the requirements for product maintenance, portfolio expansion and regulatory-compliant AI updates over the entire life cycle of a medical product are increasing.
Over the years, CNN-based models have established themselves as a reliable solution for clearly defined, image-related analysis tasks - especially where efficiency, traceability, low latency and controllable validation are crucial. Accordingly, CNN architectures can still be found today in a large number of approved AI functions, especially as a component of deterministic image processing and assistance pipelines.
New from 2026: Vision Foundation Models as a platform-capable representation layer
From 2026, Vision Foundation Models will establish themselves not as a replacement, but as an additional, platform-capable representation layer - usable across modalities, device variants and product lines.
For manufacturers, this means
- Less need for completely newly developed task models
- Reduced annotation effort for product updates
- Faster time-to-market for new AI functions
- Better reuse across product generations
The future therefore lies not in „one model“, but in a modular model ecosystem: CNNs for robust, certification-related core functions, supplemented by Foundation Model-based components for context-rich, data-driven extensions.
What role do CNNs, transformers and hybrid models play from a production perspective?
For MedTech applications, the choice of model class is less an academic question than a product, platform and approval decision.
Classification of the roles in the product:
- CNN's carry the stable, certification-related core for clearly defined, latency-critical functions.
- Foundation Models provide a platform-capable representation layer.
- Hybrid models combine CNN efficiency and global contextual understanding in one Model architecture (e.g. ConvNeXT).
CNNs - why they remain the production-related industry standard
CNNs are particularly suitable for functions that need to be stable, explainable and easy to control from a regulatory perspective.
Strengths:
- Predictable latency and resource requirements
- Stability across software versions
- Easy-to-use validation and change control
Typical fields of application:
- Real-time functions on the device (OR, ultrasound, robotics)
Examples: Track instruments/anatomical structures in live video; mark „keep-out“ zones in the OR image because latency and stability are critical. - Quality assurance, pre-processing, safety-critical pipelines
Examples: Artifact detection (metal) before the actual analysis; deterministic anonymization/masking of overlays before data export (e.g. with ResNet, EfficientNet).
Why CNNs here? Because Predictable latency, Stable versioning and Well controllable validation are required.
Transformer & Vision Foundation Models - why they are becoming platform enablers
Vision Foundation Models are pre-trained models that learn on very large, heterogeneous image data sets and thus generate robust, reusable representations. Their added value lies less in individual tasks than in their scalability across products.
Strengths:
- Common representations across many image types
- Robustness against device and protocol variations
- Fast expansion of new software features through fine-tuning
Typical fields of application:
- Scalable feature rollout via installed systems
Examples: A new segmentation function (e.g. organ/lesion) is rolled out across several scanner generations without having to develop a completely new task model for each device type. - Context-rich segmentation and classification
Examples: Multi-organ segmentation as a basis for volumetric measurements; „Findings suggestions“ (e.g. marking conspicuous regions) as assistance; better generalization for rare image constellations because the representation knowledge is broader. - Annotation assistance
Examples: Radiologists/pathologists click roughly, the model provides precise contours („scribble-to-mask“); pre-annotation for training data, which then only needs to be corrected (reduces labeling effort).
Why Foundation Models here? Because they are Reusable representation layer work across modalities and variants and updates accelerate can.
Hybrid models - evolution instead of disruption
Strengths:
- Combining local CNN efficiency with global contextual understanding
- Existing CNN pipelines remain usable
- Can be introduced incrementally and under regulatory control
Typical fields of application:
- More precise segmentation with variable image quality
Examples: Ultrasonic segmentation with strongly varying operator settings; robust contours despite shadowing/noise; combination of local edge features (CNN strength) and global context (transformer strength). - Migration of existing models towards foundation model stacks
Examples: Existing CNN segmentation is replaced by a hybrid backbone to improve generalization across device variants, while input/output interfaces remain stable (lower integration risk). - Balance of performance, use of resources and interpretability
Examples: Models that need to run on limited hardware but still require global context (e.g. large FOV images).
Why hybrid here? Because „best of both“ in a deployable model is required - often as a pragmatic compromise between real-time/edge and context capability.
What does this mean for the product and portfolio strategies of MedTech manufacturers?
For medtech manufacturers, it is crucial that AI models are long-lasting product components, not one-off research artifacts.
Foundation Models primarily change like AI is integrated into products:
- away from isolated task models,
- towards platform-based AI stacks that support multiple applications.
CNN-based components remain central, stable anchor points, especially where:
- latency is critical,
- hardware is defined,
- regulatory change budgets are limited.
Where are foundation models used today in close proximity to the product?
Radiology systems
- Strategy: CNN-based pre-processing + analysis by Foundation Models
- Benefit: Robust analysis across scanner generations, faster feature updates
- Example: MedSAM2 for 3D segmentation with reduced annotation effort
Surgery & image-guided intervention
- Strategy: CNNs for real-time + Foundation models for assistance functions
- Benefit: Secure real-time cores with flexibly expandable software
- Example: YOLO for instrument tracking, SAM2 for intraoperative segmentation
Ultrasonic platforms
- Strategy: Hybrid models for variable image quality
- Benefit: Robust performance across probes, operators and device variants
- Example: Swin Transformer combined with CNN backbones
Data protection, data preparation & OEM workflows
- Strategy: CNNs for deterministic anonymization, foundation models for feature extraction
- Benefit: Secure training pipelines, better data reuse
Conclusion: What MedTech companies should do now
2026 is the starting point for a strategic re-architecture of AI stacks in medical technology.
- Foundation Models become platform-enabled enablers for innovation.
- CNN-based models remain essential for certification-related, latency-critical product functions.
- Hybrid approaches enable a low-risk, incremental transition.
Recommended strategy:
A modular AI stack that protects existing CNN-based products, gradually adds foundation model capabilities and scales in a regulatory controllable way - as a resilient foundation for the next decade of medical imaging in medical technology.
FAQ: Foundation models in medical technology
Will Foundation Models replace classic CNNs in MedTech products?
No. Foundation models do not replace CNNs in medical technology, but strategically complement them. CNNs remain indispensable for latency-critical, deterministic and regulatory core functions, while foundation models enable additional scaling and reusability.
Why are foundation models considered product-ready for MedTech applications from 2026?
From 2026, vision foundation models will be stable, reproducible and controlled enough to be integrated into existing product and platform architectures for the first time. They can be specifically fine-tuned, versioned and embedded in modular AI stacks without fundamentally calling existing approvals into question.
Are foundation models even realistically applicable from a regulatory perspective?
Yes - as long as they are not used as a monolithic replacement, but as a clearly defined, modular extension. In hybrid architectures, certified CNN components remain stable and unchanged in the safety-critical core, while foundation model-based functions are introduced with clearly defined intended use, frozen model state and separate validation. In this way, foundation models can be treated as controllable software components for regulatory purposes - not as a self-learning black box in the field.
What role do hybrid models play for existing MedTech products?
Hybrid models are the most pragmatic migration path. They combine the efficiency and stability of existing CNN pipelines with the global contextual understanding of transformers and thus enable innovation without disruptive system redevelopment.
What is the key strategic recommendation for MedTech manufacturers?
The development of a modular AI stack. Instead of individual task models, manufacturers should rely on platform-capable architectures that protect existing CNN products, integrate foundation models in a targeted manner and scale in a way that can be controlled by regulators in the long term.
